Kenneth B. Ain, MD

Medical Oncology,  Thyroid Cancer

1. Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis Thyroid. 2015 Oct;25(10):1097-105. McLeod DS, Jonklaas J, Brierley JD, Ain KB, Cooper DS, Fein HG, Haugen BR, Ladenson PW, Magner J, Ross DS, Skarulis MC, Steward DL, Xing M, Litofsky DR, Maxon HR, Sherman SI.
   View Publication
2. Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros. Endocrine. 2015 Sep;50(1):61-6. Ain KB.
   View Publication
3. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012. J Clin Endocrinol Metab. 2015 Sep;100(9):3270-9. Carhill AA, Litofsky DR, Ross DS, Jonklaas J, Cooper DS, Brierley JD, Ladenson PW, Ain KB, Fein HG, Haugen BR, Magner J, Skarulis MC, Steward DL, Xing M, Maxon HR, Sherman SI.
   View Publication
4. Reversible cognitive, motor, and driving impairments in severe hypothyroidism. Thyroid. 2015 Jan;25(1):28-36. Smith CD, Grondin R, LeMaster W, Martin B, Gold BT, Ain KB.
   View Publication
5. Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma. Thyroid. 2013 Jan; 23(1):64-9. PMID: 22971127. Gal TJ, Streeter M, Burris J, Kudrimoti M, Ain KB, Valentino J.
   View Publication
6. American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012 Nov; 22(11):1104-39. PMID: 23130564. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle For The American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce RM.
   View Publication
7. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab. 2012 Jun; 97(6):E878-87. PMID: 22496497. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI.
   View Publication
8. Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs. J Nat Prod. 2012 Mar 23; 75(3):385-93. PMID: 22324723. Pettit GR, Rosenberg HJ, Dixon R, Knight JC, Hamel E, Chapuis JC, Pettit RK, Hogan F, Sumner B, Ain KB, Trickey-Platt B.
   View Publication
9. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma. Endocrine. 2011 Apr; 39(2):148-52. PMID: 21243446. Alapat DV, Ain KB, Sloan DA, Monaghan KG, Karabakhtsian RG. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
   View Publication
10. Radioiodine therapy in patients with stage I differentiated thyroid cancer. Thyroid. 2010 Dec; 20(12):1423-4. PMID: 21054207. Jonklaas J, Cooper DS, Ain KB, Bigos T, Brierley JD, Haugen BR, Ladenson PW, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI.
    View Publication

Cancer Center Member

Research Focus

Programs

• Translational Oncology

Insurance Information

Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers